COO’s Assessment that Exam Cheating + Pre-Revenue Biotech = Fraud Concerns
One of the biggest potential challenges for investors in pre-revenue biotech companies preparing to IPO in Hong Kong may be…
One of the biggest potential challenges for investors in pre-revenue biotech companies preparing to IPO in Hong Kong may be…
I-OnAsia’s COO James Tunkey has been asked to present to the Society of Corporate Compliance and Ethics on October 25th…
As I put my chubby thumbs and forefingers to keys, I could not avoid ruminating about The Donald’s never-ending tweet-screaming…
While celebrating or bemoaning (depending upon your perspective) the resumption of sovereignty or handover or takeover of Hong Kong to…
I-OnAsia’s Chief Operating Officer provided a briefing to New York Chapter of The Society of Former FBI Agents at a…
I apologize profusely to those of you who tinkled regarding my failure to ruminate, at least publicly, over the last…













